Literature DB >> 24759650

Avidity of antibodies against infecting pneumococcal serotypes increases with age and severity of disease.

Amelieke J H Cremers1, Jonneke Lut2, Peter W M Hermans2, Jacques F Meis3, Marien I de Jonge2, Gerben Ferwerda2.   

Abstract

The incidence of invasive pneumococcal disease (IPD) rises with age. Among adult IPD patients, the avidity of antipneumococcal polysaccharide antibodies against the infecting serotype increased with age and severity of disease, indicating that susceptibility to IPD in the elderly may rather be due to flaws in other aspects of opsonophagocytosis.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24759650      PMCID： PMC4054233          DOI： 10.1128/CVI.00147-14

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  17 in total

1.  Contribution of serotype-specific IgG concentration, IgG subclasses and relative antibody avidity to opsonophagocytic activity against Streptococcus pneumoniae.

Authors:  M Anttila; M Voutilainen; V Jäntti; J Eskola; H Käyhty
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

2.  Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity.

Authors:  S Romero-Steiner; D M Musher; M S Cetron; L B Pais; J E Groover; A E Fiore; B D Plikaytis; G M Carlone
Journal:  Clin Infect Dis       Date:  1999-08       Impact factor: 9.079

3.  Avidity as a determinant of the protective efficacy of human antibodies to pneumococcal capsular polysaccharides.

Authors:  W R Usinger; A H Lucas
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

4.  Magnitude, duration, quality, and function of pneumococcal vaccine responses in elderly adults.

Authors:  J B Rubins; A K Puri; J Loch; D Charboneau; R MacDonald; N Opstad; E N Janoff
Journal:  J Infect Dis       Date:  1998-08       Impact factor: 5.226

5.  Study of upper respiratory tract bacterial flora: first report. Variations in upper respiratory tract bacterial flora in patients with acute upper respiratory tract infection and healthy subjects and variations by subject age.

Authors:  Masatoshi Konno; Shunkichi Baba; Haruki Mikawa; Kohei Hara; Fumio Matsumoto; Kimitaka Kaga; Tadao Nishimura; Toshimitsu Kobayashi; Nobuhiko Furuya; Hiroshi Moriyama; Yoshitaka Okamoto; Mituru Furukawa; Noboru Yamanaka; Toshiharu Matsushima; Yasuyuki Yoshizawa; Shigeru Kohno; Kunihiko Kobayashi; Akihiro Morikawa; Shoichi Koizumi; Keisuke Sunakawa; Matsuhisa Inoue; Kimiko Ubukata
Journal:  J Infect Chemother       Date:  2006-04       Impact factor: 2.211

6.  Impact of more than a decade of pneumococcal conjugate vaccine use on carriage and invasive potential in Native American communities.

Authors:  Jennifer R Scott; Eugene V Millar; Marc Lipsitch; Lawrence H Moulton; Robert Weatherholtz; Mindy J Perilla; Delois M Jackson; Bernard Beall; Mariddie J Craig; Raymond Reid; Mathuram Santosham; Katherine L O'Brien
Journal:  J Infect Dis       Date:  2011-11-29       Impact factor: 5.226

7.  Antibody to capsular polysaccharide of Streptococcus pneumoniae at the time of hospital admission for Pneumococcal pneumonia.

Authors:  D M Musher; H M Phan; D A Watson; R E Baughn
Journal:  J Infect Dis       Date:  2000-06-30       Impact factor: 5.226

8.  Immunogenetic analysis of the immune response to pneumococcal polysaccharide.

Authors:  H E Baxendale; Z Davis; H N White; M B Spellerberg; F K Stevenson; D Goldblatt
Journal:  Eur J Immunol       Date:  2000-04       Impact factor: 5.532

9.  Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.

Authors:  Cynthia G Whitney; Monica M Farley; James Hadler; Lee H Harrison; Nancy M Bennett; Ruth Lynfield; Arthur Reingold; Paul R Cieslak; Tamara Pilishvili; Delois Jackson; Richard R Facklam; James H Jorgensen; Anne Schuchat
Journal:  N Engl J Med       Date:  2003-05-01       Impact factor: 91.245

10.  Nasopharyngeal carriage of Streptococcus pneumoniae by adults and children in community and family settings.

Authors:  Gili Regev-Yochay; Meir Raz; Ron Dagan; Nurith Porat; Bracha Shainberg; Erica Pinco; Nathan Keller; Ethan Rubinstein
Journal:  Clin Infect Dis       Date:  2004-02-17       Impact factor: 9.079
View more
  4 in total

1.  Streptococcus pneumoniae Colonization Disrupts the Microbial Community within the Upper Respiratory Tract of Aging Mice.

Authors:  Netusha Thevaranjan; Fiona J Whelan; Alicja Puchta; Eta Ashu; Laura Rossi; Michael G Surette; Dawn M E Bowdish
Journal:  Infect Immun       Date:  2016-03-24       Impact factor: 3.441

2.  Impact of a Rapid Decline in Malaria Transmission on Antimalarial IgG Subclasses and Avidity.

Authors:  Isaac Ssewanyana; John Rek; Isabel Rodriguez; Lindsey Wu; Emmanuel Arinaitwe; Joaniter I Nankabirwa; James G Beeson; Harriet Mayanja-Kizza; Philip J Rosenthal; Grant Dorsey; Moses R Kamya; Chris Drakeley; Bryan Greenhouse; Kevin K A Tetteh
Journal:  Front Immunol       Date:  2021-01-27       Impact factor: 7.561

3.  Avidity of anti-malarial antibodies inversely related to transmission intensity at three sites in Uganda.

Authors:  Isaac Ssewanyana; Emmanuel Arinaitwe; Joaniter I Nankabirwa; Adoke Yeka; Richard Sullivan; Moses R Kamya; Philip J Rosenthal; Grant Dorsey; Harriet Mayanja-Kizza; Chris Drakeley; Bryan Greenhouse; Kevin K A Tetteh
Journal:  Malar J       Date:  2017-02-10       Impact factor: 2.979

4.  Case report on a defective antibody response against pneumococcal serotype 9V in a patient with a single episode of pneumonia.

Authors:  Diana van Kessel; Thijs Hoffman; Heleen van Velzen-Blad; Bob Meek; Suzan van Mens; Jan Grutters; Ger Rijkers
Journal:  Pneumonia (Nathan)       Date:  2017-11-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.